Annual Drug Patent Expirations for POSIMIR
Posimir is a drug marketed by Innocoll and is included in one NDA. It is available from two suppliers. There are five patents protecting this drug.
This drug has forty-eight patent family members in twenty-nine countries.
The generic ingredient in POSIMIR is bupivacaine. Two suppliers are listed for this compound. Additional details are available on the bupivacaine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com